
    
      This study uses a treat and resect model where ablation is followed by a partial nephrectomy.
      This will allow for the ablation to be evaluated for necrosis and targeting accuracy. It will
      also ensure cancer safety prior validation of the HIFU device. The applied heat of HIFU
      ablation could improve hemostasis and blood loss.
    
  